Approaches to determine clinical significance of genetic variants

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 573, Issue 1-2, 2005, Pages 205-220

  MacAuley, Alasdair ^a   Ladiges, Warren C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer; DNA repair; Environmental carcinogen; Mouse genomics; Single nucleotide polymorphism

Indexed keywords

AMINO ACID; CARCINOGEN; NON PRESCRIPTION DRUG; TOXIC SUBSTANCE;

AIR QUALITY; BACTERIAL ARTIFICIAL CHROMOSOME; DIET; DNA POLYMORPHISM; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MATHEMATICAL COMPUTING; METHODOLOGY; MUTAGEN TESTING; NONHUMAN; PHENOTYPE; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRAVIOLET RADIATION; VALIDATION PROCESS; YEAST;

EID: 17044422148     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2005.01.009     Document Type: Review

References (89)

1. S.L. Gerson Clinical relevance of MGMT in the treatment of cancer J. Clin. Oncol. 20 2002 2388 2399
2. J.G. Donnelly Pharmacogenetics in cancer chemotherapy: balancing toxicity and response Ther. Drug Monit. 26 2004 231 235
3. J.C. Venter, M.D. Adams, E.W. Myers, P.W. Li, R.J. Mural, and G.G. Sutton The sequence of the human genome Science 291 2001 1304 1351
4. J.K. Pritchard Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 69 2001 124 137
5. D.E. Reich, and E.S. Lander On the allelic spectrum of human disease Trends Genet. 17 2001 502 510
6. J.K. Pritchard, and N.J. Cox The allelic architecture of human disease genes: common disease-common variant. or not? Hum. Mol. Genet. 11 2002 2417 2423
7. K.E. Lohmueller, C.L. Pearce, M. Pike, E.S. Lander, and J.N. Hirschhorn Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease Nat. Genet. 33 2003 177 182
8. P.C. Ng, and S. Henikoff SIFT: predicting amino acid changes that affect protein function Nucleic Acids Res. 31 2003 3812 3814
9. P.C. Ng, and S. Henikoff Predicting deleterious amino acid substitutions Genome Res. 11 2001 863 874
10. V. Ramensky, P. Bork, and S. Sunyaev Human non-synonymous SNPs: server and survey Nucleic Acids Res. 30 2002 3894 3900
11. S. Sunyaev, V. Ramensky, I. Koch, W. Lathe 3rd, A.S. Kondrashov, and P. Bork Prediction of deleterious human alleles Hum. Mol. Genet. 10 2001 591 597
12. S. Savas, D.Y. Kim, M.F. Ahmad, M. Shariff, and H. Ozcelik Identifying functional genetic variants in DNA repair pathway using protein conservation analysis Cancer Epidemiol. Biomarkers Prev. 13 2004 801
13. T. Xi, I.M. Jones, and H.W. Mohrenweiser Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function Genomics 83 2004 970 979
14. R.M. Taylor, A. Thistlethwaite, and K.W. Caldecott Central role for the XRCC1 BRCT1 domain in mammalian DNA single-strand break repair Mol. Cell. Biol. 22 2002 2556 2563
15. C.D. Mol, T. Izumi, S. Mitra, and J.A. Tainer DNA-bound structures and mutants reveal abasic DNA binding by APE1 and DNA repair coordination Nature 403 2000 451 455
16. D.F. Lowry, D.W. Hoyt, F.A. Khazi, J. Bagu, A.G. Lindsey, and D.M. Wilson III Investigation of the role of the histidine-aspartate pair in the human exonuclease III-like abasic endonuclease, Ape1 J. Mol. Biol. 329 2003 311 322
17. A. Marintchev, M.A. Mullen, M.W. Maciejewski, B. Pan, M.R. Gryk, and G.P. Mullen Solution structure of the single-strand break repair protein XRCC1 N-terminal domain Nat. Struct. Biol. 6 1999 884 892
18. X. Zhang, S. Morera, P.A. Bates, P.C. Whitehead, A.I. Coffer, K. Hainbucher, R.A. Nash, M.J.E. Sternberg, T. Lindahl, and P.S. Freemont Structure of an XRCC1 BRCT domain: a new protein-protein interaction module EMBO J. 17 1998 6404 6411
19. A. Dulic, P.A. Bates, X. Zhang, S.R. Martin, P.S. Freemont, T. Lindahl, and D.E. Barnes BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III Biochemistry 40 2001 5906 5913
20. R.M. Taylor, B. Wickstead, S. Cronin, and K.W. Caldecott Role of a BRCT domain in the interaction of DNA ligase III-α with the DNA repair protein XRCC1 Curr. Biol. 8 1998 877 880
21. A.E. Vidal, S. Boiteux, I.D. Hickson, and J.P. Radicella XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions EMBO J. 20 2001 6530 6539
22. R.M. Taylor, D.J. Moore, J. Whitehouse, P. Johnson, and K.W. Caldecott A cell cycle-specific requirement for the XRCC1 BRCTII domain during mammalian DNA strand break repair Mol. Cell Biol. 20 2000 735 740
23. Y. Kubota, and S. Horiuchi Independent roles of XRCC1's two BRCT motifs in recovery from methylation damage DNA Repair 2 2003 407 415
24. S.Z. Abdel-Rahman, and R.A. El-Zein The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymmphocytes by the tobacco-specific nitrosamine NNK Cancer Lett. 159 2000 63 71
25. J. Tuimala, G. Szekely, S. Gundy, A. Hirvonen, and H. Norppa Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity Carcinogenesis 23 2002 1003 1008
26. Y. Wang, M.R. Spitz, Y. Zhu, Q. Dong, S. Shete, and X. Wu From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity DNA Repair 2 2003 901 908
27. K. Drotschmann, A.B. Clark, H.T. Tran, M.A. Resnick, D.A. Gordenin, and T.A. Kunkel Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene Proc. Natl. Acad. Sci. U.S.A. 96 1999 2970 2975
28. D.P. Lin, Y. Wang, S.J. Scherer, A.B. Clark, K. Yang, E. Avdievich, B. Jin, U. Werling, T. Parris, N. Kurihara, A. Umar, R. Kucherlapati, M. Lipkin, T.A. Kunkel, and W. Edelmann An Msh2 point mutation uncouples DNA mismatch repair and apoptosis Cancer Res. 64 2004 517 522
29. E.L. Goode, C.M. Ullrich, and J.D. Potter Polymorphisms in DNA repair genes and associations with cancer risk Can. Epidemiol. Biomarkers Prev. 11 2002 1513 1530
30. W. Ladiges, J. Wiley, and A. Macauley Polymorphisms in the DNA repair gene XRCC1 and age-related disease Mech. Ageing Dev. 124 2003 27 32
31. B. Hao, H. Wang, K. Zhou, Y. Li, X. Chen, G. Zhou, Y. Zhu, X. Miao, W. Tan, Q. Wei, D. Lin, and F. He Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma Cancer Res. 64 2004 4378 4384
32. J.J. Hu, T.R. Smith, M.S. Miller, H.W. Mohrenwieser, A. Golden, and L.D. Case Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity Carcinogenesis 22 2001 917 922
33. H.W. Mohrenweiser, D.M. Wilson III, and I.M. Jones Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes Mut. Res. 526 2003 93 125
34. P.G. Shields, and C.C. Harris Cancer risk and low-penetrance susceptibility genes in gene-environment interactions J. Clin. Oncol. 18 2000 2309 2315
35. M. Berwick, and P. Vineis Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review J. Natl. Cancer Inst. 92 2000 874 897
36. P. Giraldo, and L. Montoliu Size matters: use of YACs, BACs and PACs in transgenic animals Transgenic Res. 10 2001 83 103
37. T.M. Wintermantel, A.K. Mayer, G. Schutz, and E.F. Greiner Targeting mammary epithelial cells using a bacterial artificial chromosome Genesis 33 2002 125 130
38. L.R. Cardon, and J.I. Bell Association study designs for complex diseases Nat. Rev. Genet. 2 2001 91 99
39. K.M. Weiss, and J.D. Terwilliger How many diseases does it take to map a gene with SNPs? Nat. Genet. 26 2000 151 156
40. J.D. Terwilliger, F. Haghighi, T.S. Hiekkalinna, and H.H.H. Goring A biased assessment of the use of SNPs in human complex traits Curr. Opin. Genet. Dev. 12 2002 726 734
41. N.G. Copeland, N.A. Jenkins, and D.L. Court Recombineering: a powerful new tool for mouse functional genomics Nat. Rev. Genet. 2 2001 769 779
42. P. Liu, N.A. Jenkins, and N.G. Copeland A highly efficient recombineering-based method for generating conditional knockout mutations Genome Res. 13 2003 476 484
43. E.-C. Lee, D. Yu, J. Martinez di Velasco, L. Tessarollo, D.A. Swing, D.L. Court, N.A. Jenkins, and N.G. Copeland A highly efficient Escheria coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA Genomics 73 2001 56 65
44. D.L. Court, J.A. Sawitzke, and L.C. Thomason Genetic engineering using homologous recombination Ann. Rev. Genet. 36 2002 361 388
45. J.P.P. Muyrers, Y. Zhang, V. Benes, G. Testa, W. Ansorge, and A.F. Stewart Point mutation of acterial artificial chromosomes by ET recombination EMBO Rep. 1 2000 239 243
46. J.P.P. Muyrers, Y. Zhang, G. Testa, and A.F. Stewart Rapid modification of bacterial artificial chromosomes by ET-recombination Nucleic Acids Res. 27 1999 1555 1557
47. Y. Zhang, F. Buchholz, J.P.P. Muyrers, and A.F. Stewart A new logic for DNA engineering using recombination in Escherichia coli Nat. Genet. 20 1998 123 128
48. G. Testa, Y. Zhang, K. Vintersten, V. Benes, W.M.M. Pim Pijnappel, I. Chambers, A.J.H. Smith, A.G. Sith, and A.F. Stewart Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles Nat. Biotech. 21 2003 443 447
49. Y. Yang, and B. Seed Site-specific gene targeting in mouse embryonic stem cells with intact bacterial artificial chromosomes Nat. Biotech. 21 2003 447 451
50. D.M. Valenzuela, A.J. Murphy, D. Frendewey, N.W. Gale, A.N. Economides, W. Auerbach, W.T. Poueymirou, N.C. Adams, J. Rojas, J. Yasenchak, R. Chernomorsky, M. Boucher, A.L. Elsasser, L. Esau, J. Zheng, J.A. Griffiths, X. Wang, H. Su, Y. Xue, M.G. Dominguez, I. Noguera, R. Torres, L.E. Macdonald, A.F. Stewart, T.M. DiChiara, and G.D. Yancopoulos High-throughput engineering on the mouse genome coupled with high-resolution expression analysis Nat. Biotech. 21 2003 652 659
51. C. Deng, and M.R. Capecchi Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus Mol. Cell Biol. 12 1992 3365 3371
52. M. Lauth, F. Spreafico, K. Dethleffsen, and M. Meyer Stable and efficient cassette exchange under non-selectable conditions by combined use of two site-specific recombinases Nucleic Acids Res. 30 2002 e115
53. A.F. Kolb Selection-marker-free modification of the murine beta-casein gene using a lox2272 site Anal. Biochem. 290 2001 260 271
54. S. Soukharev, J.L. Miller, and B. Sauer Segmental genomic replacement in embryonic stem cells by double lox targeting Nucleic Acids Res. 27 1999 e21
55. A. Baer, and J. Bode Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes Curr. Opin. Biotechnol. 12 2001 473 480
56. P. Liu, N.A. Jenkins, and N.G. Copeland Efficient Cre-loxP-induced mitotic recombination in mouse embryonic stem cells Nat. Genet. 30 2002 66 72
57. L. Lefebvre, N. Dionne, J. Karaskova, J.A. Squire, and A. Nagy Selection for transgene homozygosity in embryonic stem cells results in extensive of heterozygosity Nat. Genet. 27 2001 257 258
58. T. Kafri Lentivirus vectors: difficulties and hopes before clinical trials Curr. Opin. Mol. Ther. 3 2001 316 326
59. A. Rangarajan, and R.A. Weinberg Comparative biology of mouse versus human cells: modelling human cancer in mice Nat. Rev. Cancer 3 2003 952 959
60. R.A. DePinho The age of cancer Nature 408 2000 248 254
61. E. Robanus-Maandag, M. Dekker, M. van der Valk, M.L. Carrozza, J.C. Jeanny, J.H. Dannenberg, A. Berns, and H. te Riele p107 is a suppressor of retinoblastoma development in pRb-deficient mice Genes Dev. 12 1998 1599 1609
62. K. Wei, R. Kucherlapati, and W. Edelmann Mouse models for human DNA mismatch-repair gene defects Trends Mol. Med. 8 2002 346 353
63. L.B. Meira, D.L. Cheo, A. Reis, R.E. Hammer, D.K. Burns, and E.C. Freidberg Genetic interaction between Hap1 (Ref1) and p53 Nat. Genet. 17 1997 145
64. D.L. Cheo, L.B. Meira, D.K. Burns, A.M. Reis, T. Issac, and E.C. Friedberg UVB radiation-induced skin cancer in mice defective in Xpc Trp53 and Apex (Hap1) genes: genotype-specific effects on cancer predisposition and pathology of tumors Cancer Res. 60 2000 1580 1584
65. D.C. Cabelof, Z.M. Guo, J.J. Raffoul, R.W. Sobol, S.H. Wilson, A. Richardson, and A.R. Heydari Base excision repair deficiency caused by polymerase β haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens Cancer Res. 63 2003 5799 5808
66. R.S. Tebbs, L.H. Thompson, and J.E. Cleaver Rescue of Xrcc1 knockout mouse embryo lethality by transgene-complementation DNA Repair 2 2003 1405 1417
67. K.W. Kohn Molecular interaction map of the mammalian cell cycle control and DNA repair systems Mol. Biol. Cell 10 1999 2703 2734
68. K.W. Kohn Molecular interaction maps as information organizers and simulation guides Chaos 11 2001 84 97
69. G.T. Wong Speed congenics: applications for transgenic and knock-out mouse strains Neuropeptides 36 2002 230 236
70. M.T. McManus, and P.A. Sharp Gene silencing in mammals by small interfering RNAs Nat. Rev. Genet. 3 2002 737 747
71. J. Hall Unravelling the general properties of siRNAs: strength in numbers and lessons from the past Nat. Rev. Genet. 5 2004 552 557
72. A. Reynolds, D. Leake, Q. Boese, S. Scaringe, W.S. Marshall, and A. Khvorova Rational siRNA design for RNA interference Nat. Biotech. 22 2004 326 330
73. V. Mittal Improving the efficiency of RNA interference in mammals Nat. Rev. Genet. 5 2004 355 365
74. T. Abbas-terki, W. Blanco-Bose, N. Delgon, W. Pralong, and P. Aebischer Lentiviral-mediated RNA interference Hum. Gene Ther. 13 2002 2197 2201
75. J.Y. Yu, S.L. DeRuiter, and D.L. Turner RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells Proc. Natl. Acad. Sci. U.S.A. 100 2002 6047 6052
76. D.A. Rubinson, C.P. Dillon, A.V. Kwiatkowski, C. Sievers, L. Yang, J. Kopinja, D.L. Rooney, M.M. Ihrig, M.T. McManus, F.B. Gertler, M.L. Scott, and L. Van Parijs A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference Nat. Genet. 33 2003 401 406
77. N.H. Barton, and P.D. Keightley Understanding quantitative genetic variation Nat. Rev. Genet. 3 2002 11 21
78. T.F.C. Mackay The genetic architecture of quantitative traits Ann. Rev. Genet. 35 2001 303 339
79. N.J. Risch Searching for genetic determinants in the new millennium Nature 405 2000 847 856
80. D.E. Featherstone, and K. Broadie Wrestling with pleiotropy: genomic and topological analysis of the yeast gene expression network Bioessays 24 2002 267 274
81. E.Y. Cho, A. Hildesheim, C.J. Chen, M.M. Hsu, I.H. Chen, B.F. Mittl, P.H. Levine, M.Y. Liu, J.Y. Chen, L.A. Brinton, Y.J. Cheng, and C.S. Yang Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1 Cancer Epidemiol. Biomarkers Prev. 12 2003 1100 1104
82. M.W. Yu, S.Y. Yang, I.J. Pan, C.L. Lin, C.J. Liu, Y.F. Liaw, S.M. Lin, P.J. Chen, S.D. Lee, and C.J. Chin Polymorphisms in XRCC1 and glutathione S-transferase gene and hepatitis B-related hepatocellular carcinoma J. Natl. Cancer Inst. 95 2003 1485 1488
83. R.R. Misra, D. Ratnasinghe, J.A. Tangrea, J. Virtano, M.R. Andersen, M. Barrett, P.R. Taylor, and D. Albanes Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smolers in Finland Cancer Lett. 191 2003 171 178
84. R.S. Tebbs, M.L. Flannery, J.J. Meneses, A. Hartmann, J.D. Tucker, L.H. Thompson, J.E. Cleaver, and R.A. Pedersen Requirement for the Xrcc1 DNA base excision repair gene during early mouse development Dev. Biol. 208 1999 513 529
85. L.B. Meira, D.L. Cheo, A. Reis, N. Claij, D.K. Burns, H. te Reile, and E.C. Friedberg Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer DNA Repair 1 2002 929 934
86. A.H. Reitmair, J.C. Cai, M. Bjerknes, M. Redston, H. Cheng, M.T.L. Pind, K. Hay, A. Mitri, B.V. Bapat, T.W. Mak, and S. Gallinger Msh2 deficiency contributes to accelerated Apc-mediated intestinal tumorigenesis Cancer Res. 56 1996 2922 2926
87. K.M. Frank, N.E. Sharpless, Y. Gao, J.M. Sekiguchi, D.O. Ferguson, C. Zhu, J.P. Manis, J. Horner, R.A. DePinho, and F.W. Alt DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway Mol. Cell 5 2000 993 1002
88. M.T. Hemann, J.S. Fridman, J.T. Zilfou, E. Hernando, P.J. Paddison, C. Cordon-pCardo, G.J. Hannon, and S.W. Lowe An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo Nat. Genet. 33 2003 396 400
89. J.L. Badano, and N. Katsanis Beyond Mendel: an evolving view of human genetic disease transmission Nat. Rev. Genet. 3 2002 779 789